FORT MYERS, Fla., Nov. 03, 2016 -- Southwest Florida’s premier facial aesthetic medical spa, Azul Cosmetic Surgery and Medical Spa, announced today that the manufacturer of their proprietary Azul skincare line, Trilogy Laboratories, is a finalist to receive the “Manufacturer of the Year” award from the Manufacturers Association of Florida (MAF). This is a major achievement for both Azul and Trilogy Laboratories, which together have developed the Azul line of medical-grade skincare products and the Azul Blue Diamond line in response to patient requests for scientifically proven, advanced skincare to reverse the signs of aging.
“Being able to see first-hand the effects of the Azul skincare line makes all the work and research worth it,” states Dr. Kristen Flaharty, CEO of Trilogy Laboratories, who developed the high-grade Azul skincare line with her husband, facial plastic surgeon and Medical Director of Azul, Dr. Patrick Flaharty. “We really let the product speak for itself, so this is a big win for us. I’m very proud of my team at Trilogy Laboratories.” This nomination comes as the MAF recognizes publicly the research, work and results of Trilogy’s products, manufacturing processes, distribution and growth in the industry. Another boon for the lab is its production of private-label skincare products customized for individual spas to create their own branding.
Azul Cosmetic Surgery and Medical Spa, run by power couple Dr. Patrick Flaharty, facial plastic surgeon, and his wife Dr. Kristen Flaharty, have three locations in Bonita Springs, Naples and Fort Myers, Florida. With over 20 years of pharmaceutical product development experience, Dr. Kristen Flaharty developed Trilogy Laboratories in 2014 to bring the science of breakthrough skincare advancements and premium ingredients at optimum concentrations to products women can use daily with ease and confidence. Science is at the heart of all Trilogy’s products, a welcome asset to patients looking to maintain their investment in aesthetic skincare treatments.
The latest line developed by Trilogy Laboratories, called ID Skin by Integraderm, was created exclusively for the salon and spa industry, and Trilogy recently partnered with Florida Academy of Skincare to use these products to train the next wave of talented estheticians. Trilogy products are sold at Azul locations, top salons and spas, and are all proudly USA-made in Trilogy’s own manufacturing facility, located in Fort Myers, Florida.
About Azul Cosmetic Surgery and Medical Spa:
Founded by one of America’s most accomplished facial plastic surgeons, Dr. Patrick Flaharty, Azul Cosmetic Surgery and Medical Spa specializes in providing the best treatments and skincare options available in both surgical and non-surgical facial aesthetics. With three locations in Naples, Bonita Springs and Fort Myers, Florida, the state-of-the-art facilities offer a comfortable, friendly setting. Technicians are highly skilled at providing the best skincare solutions to patients. The staff takes pride in offering top-notch personalized skincare procedures in a welcoming environment.
To learn more, or to schedule a consultation, please visit:
http://www.azulbeauty.com/.
About the Manufacturers Association of Florida:
The Manufacturers Association of Florida (MAF) was organized in early 2006 to improve Florida’s manufacturing business climate. The MAF is comprised of manufacturers and those who serve them, who want to set the direction for manufacturing policy. The MAF brings together companies across the state to form prosperous partnerships and make a difference in Florida’s economy. Priority issues are determined by the board, based on input from MAF members, committees and board members.
Sherrie Jagolino 734-402-8843 [email protected]


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 



